Global Market" has been added to ResearchAndMarkets.com's offering.The global fusion proteins market is poised to expand ...

October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound ...

Showcase your company news with guaranteed exposure both in print and online Join us as we honor real estate professionals and companies in the Triad region… Join us as we continue our event series ...

Elysium is Arizona’s most advanced estate - a $15M fusion of architecture and technology rarely… Scottsdale, Ariz. — Evolve PR & Marketing, Arizona’s largest public relations agency, was honored at ...

Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...